Japan's Nitto Denko has developed what it claims is the world's
first biodegradable gene carrier that can be used to transfer
foreign genes into animal cells. Because the polymer breaks down in
the body, it exhibits extremely...
Researchers in the US say they have achieved a critical objective
in an effort to create a living organism from DNA building-blocks.
The process used could be used to create bespoke cell-based
organisms to carry out a range of functions,...
Researchers in the US have published the first raft of data from
the GENSAT project, designed to track the maze of connections
between cells in the CNS.
Galapagos Genomics has published details of its RNAi-based gene
silencing technology, based on adenovirus vectors, that is
effective in a range of cell types.
Amersham will no longer act as a distributor for Epoch Bioscience's
MGB Eclipse range of probe systems after failing to meet sales
targets, according to the latter company.
Cardinal Health is to acquire 100 per cent ownership of protein
production specialist Gala Biotech for $15.5 million (€13.2m)in a
move to bolster its drug development services business.
Amersham Biosciences has added a mouse genome product in its
CodeLink range, used for drug target identification, pathway
characterisation and drug effect predictions.
Italian researchers suggest that patients with atrial fibrillation
may have a genetic predisposition linked to expression of
pro-inflammatory proteins.
Merck KGaA buys ProteoPlex in a move designed to shore up its
position in the emerging microarray market, estimated to reach $2
billion (€1.76bn) in 2008.
Applied Biosystems has unveiled a gene expression analysis product
that allows researchers to conduct studies on the entire human
genome using a single microarray.
There is a growing reliance on the use of tissue microarrays to
accelerate the examination of histological samples used in drug
discovery, according to a new report from BioInformatics.
Iceland's deCODE genetics has initiated high-throughput screening
on its Neuregulin 1 pathway targets in schizophrenia in
collaboration with partner Roche.
Research into genomes of the natural world took a step forward this
week with the announcement from Diversa corporation that it is to
jointly collaborate with the US Department of Energy's Joint Genome
Institute (JGI) to discover...
Specialists in cellular analysis Cyntellect this week announced the
issuance of a new patent covering the company's Laser Enabled
Analysis and Processing (LEAP) technology platform.
Aclara BioSciences, a US company involved in tools for drug
discovery, this week introduced new toxicology applications that
expand the capabilities of the eTag Assay System.
Drug target validation has become the critical step in maintaining
profitability for the pharmaceutical industry, claims a new report
from market research company Business Communications. Drug
developers must accelerate identification...
